Notice for efanesoctocog alfa (Sanofi-Aventis Australia Pty Ltd)
Active ingredients
efanesoctocog alfa
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for intravenous application
Indication
Treatment of Haemophilia A
Therapeutic area
Haematology